top of page

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Opdyta 240mg Injection

Opdyta 240mg Injection

Manufacturer/Marketed By : BRISTOL MYERS SQUIBB

$2542.86 $2288.57

Sidmex Inovia offers bulk export supply of Opdyta 240mg Injection (NIVOLUMAB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and tenders:...

NIVOLUMAB

Active Pharmaceutical Ingredient

Opdyta 240mg Injection

SKU OPDYTA-240MG-INJECTION
Original price

$2,542.86

Sale price

$2,288.57

Sidmex Inovia offers bulk export supply of Opdyta 240mg Injection (NIVOLUMAB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.

Documents, cold-chain shipping and tenders: see our Export FAQ.

Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada

Related products we supply: Alburel 20 gm/100 ml Injection

Opdyta 240mg Injection consists of the active substance Nivolumab. It is indicated for the treatment of cancers of the skin, lungs, kidneys, lymph nodes, bladder, oesophagus, and urinary tract. This medicine is indicated when the cancer has recurred after treatment using medicines, surgery, and radiation. It is a medication that helps the immune system fight cancer more effectively. It works by targeting and inhibiting specific molecules that can suppress or weaken the immune system's ability to recognise and attack cancer cells. Blocking these molecules can enhance the immune response against cancer and potentially shrink or slow tumour growth. One of the benefits of opdyta immunotherapy drugs, including it, is that they can produce long-lasting responses in some patients, even after treatment is stopped. This contrasts with traditional chemotherapy and radiation therapy, which typically only provide temporary benefits and can have significant side effects. It is contraindicated in patients with a severe allergic reaction to the drug or its components. It is also contraindicated in patients with certain autoimmune disorders, such as lupus or rheumatoid arthritis, because the drug can further stimulate the immune system and exacerbate these conditions. Additionally, it should be used cautiously in patients with a history of organ transplants. Opdyta 240mg injection price is the same for all the locations. You can buy Opdyta 240mg injection online.

Active Pharmaceutical Ingredient

NIVOLUMAB

Uses

• Advanced skin cancer (melanoma)
• Skin cancer that recurs after surgery
• Advanced non-small cell lung cancer
• Advanced kidney cancer
• Hodgkin’s lymphoma (lymph node disease)
• Advanced cancer of the head and neck
• Advanced urinary tract and bladder cancer
• Advanced oesophageal cancer

Benefits

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Side Effects

Opdyta injection side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Most Common Side Effects

• Fatigue
• Nausea
• Skin rash
• Itching
• Loss of appetite
• Diarrhea
• Constipation
• Joint pain
• Headache

Common Side Effects

• Pneumonitis (inflammation of lung tissue)
• Colitis (inflammation of the colon)
• Hepatitis (inflammation of the liver)
• Hypothyroidism
• Hyperthyroidism
• Adrenal insufficiency (a condition in which the adrenal glands do not produce enough hormones).
• Severe allergic reactions
• Infusion-related reactions
• Confusion
• Seizures
• Neuropathy
• Eye disorders (such as uveitis or iritis)

How To Use

Opdyta 240mg Injection is a medication administered by a healthcare professional, typically in a hospital or clinic setting. The medication is given as an intravenous (IV) infusion by a healthcare professional. The infusion typically takes several hours. You will be closely monitored during and after the infusion to ensure the medication works effectively and to watch for any side effects. The opdyta 240 mg dosage and frequency of administration will depend on the condition being treated and your circumstances. Your healthcare provider will determine the appropriate dosage and schedule for you.

Safety Advice

• Breast Feeding: It is unknown whether Opdyta 240mg Injection is excreted in human breast milk, so a breastfeeding woman should discuss the potential risks and benefits of the medication with their healthcare provider before starting treatment.
• Alcohol: There are no known interactions between Opdyta 240mg Injection and alcohol. However, it is generally recommended to avoid consuming alcohol while being treated for a medical condition, as alcohol can potentially interfere with the effectiveness of the medication and increase the risk of side effects.
• Liver: Opdyta 240mg Injection should be used cautiously in individuals with liver disease, as the medication is primarily metabolised in the liver and could potentially worsen liver function. Your healthcare provider will monitor you closely if you have liver disease and adjust your dosage if necessary.
• Lungs: Opdyta 240mg Injection should be used cautiously in individuals with lung disease, as the medication can potentially worsen lung function. Your healthcare provider will monitor you closely if you have lung disease and adjust your dosage if necessary. If you have lung disease or a history of respiratory problems, discussing the potential risks and benefits of treatment with your healthcare provider is important. Your healthcare provider may recommend additional monitoring or testing to ensure the medication is not causing any adverse effects on your lungs.
• Driving: Patients receiving Opdyta 240mg Injection should avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
• Pregnancy: Opdyta 240mg Injection is unsafe for a developing foetus and is not recommended during pregnancy as it can cause harm to the developing foetus.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page